The Lighthouse®
Why? Because U.S. security does not require a resounding Ukrainian victory. Ditto for the rest of Europe. What everybody’s security does require, however, is that this new land war in Europe not escalate into a nuclear conflict. Face-saving settlements and then popular referenda—we need them.
READ MORE »
Steve H. Hanke, John Greenwood (Wall Street Journal)
The recent devastating high inflation will end soon—that’s the good news. But here comes different bad news: a recession; and the Fed, which treats the money supply as its plaything, is responsible for both. What’s next?
READ MORE »
Richard K. Vedder (Minding the Campus)
The academy in the United States was once considered a truly “exceptional” place—but not so much anymore. The biggest single cause of this descent into mediocrity? Federal financial aid. What reforms could work?
READ MORE »
Raymond J. March
Leqembi is one of only two drugs approved by the FDA to treat Alzheimer’s in the past 17 years. The other one is Aduhelm. Why so few? Because most drugs, unlike these two, were not part of the Accelerated Approval Program. And persons, who needn’t have, died. Time to streamline the FDA.
READ MORE »
The Lighthouse® is the weekly email newsletter of the Independent Institute.
Subscribe now, or browse Back Issues.
Volume 26, Issue 8: February 22, 2023
Ivan Eland (MSN News)
Why? Because U.S. security does not require a resounding Ukrainian victory. Ditto for the rest of Europe. What everybody’s security does require, however, is that this new land war in Europe not escalate into a nuclear conflict. Face-saving settlements and then popular referenda—we need them.
READ MORE »
In Search of Monsters to Destroy
The Folly of American Empire and the Paths to Peace
The Folly of American Empire and the Paths to Peace
By Christopher J. Coyne
Steve H. Hanke, John Greenwood (Wall Street Journal)
The recent devastating high inflation will end soon—that’s the good news. But here comes different bad news: a recession; and the Fed, which treats the money supply as its plaything, is responsible for both. What’s next?
READ MORE »
Richard K. Vedder (Minding the Campus)
The academy in the United States was once considered a truly “exceptional” place—but not so much anymore. The biggest single cause of this descent into mediocrity? Federal financial aid. What reforms could work?
READ MORE »
Raymond J. March
Leqembi is one of only two drugs approved by the FDA to treat Alzheimer’s in the past 17 years. The other one is Aduhelm. Why so few? Because most drugs, unlike these two, were not part of the Accelerated Approval Program. And persons, who needn’t have, died. Time to streamline the FDA.
READ MORE »The Beacon: New Blog Posts
- Choice Words From Biden, by K. Lloyd Billingsley
- A Possible Solution for the War in Ukraine, by Ivan Eland
- López Obrador´s Honeymoon With Cuba, by Alvaro Vargas Llosa
- The Inflation Outlook: By the Numbers, by Randall G. Holcombe
- Bureaucrats Gone Criminal, by Craig Eyermann
- Transportation Secretary Buttigieg Goes Off the Rails, by K. Lloyd Billingsley
Catalyst: New Articles
- The History of Slavery You Weren’t Taught in School, by Lawrence W. Reed
- Japan Makes Good on Goal to Restart Nuclear Plants, by Paige Lambermont
- Lockdown Governors Largely Go Unpunished, by Brady Leonard
- Barrios Tropicales: The Making of Green Neighborhoods, by Scott Beyer
